Culley C. Carson

Key Clinical Trials in Erectile Dysfunction

• Broschiertes Buch

Produktbeschreibung

This book represents a critical appraisal of the major clinical trials that have had a significant impact on clinical research and practice during the last decade. Each trial follows a strict format, starting with reference to the original source of publication, details on the key investigators and their methods of research. The strengths and weaknesses of each trial are discussed as well as their influence on clinical practice. Articles are complemented by a diagrammatic summary of the trial design and the key findings. It is estimated that over 20 million men in Europe alone suffer at some time in their life from erectile dysfunction (ED). This is the first book to bring together in a single volume a critical review of all the major trials in ED.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Springer / Springer London / Springer, Berlin
• Artikelnr. des Verlages: 11682912, 978-1-84628-427-4
• 2007 edition
• Seitenzahl: 79
• Erscheinungstermin: 6. Dezember 2006
• Englisch
• Abmessung: 133mm x 208mm x 5mm
• Gewicht: 120g
• ISBN-13: 9781846284274
• ISBN-10: 1846284279
• Artikelnr.: 20813031

Autorenporträt

Culley C. Carson, University of North Carolina at Chapel Hill, NC, USA

Inhaltsangabe

Yohimbine: first oral pharmacotherapy.- Phenoxybenzamine: an early intracavernosal agent.- Intracavernosal therapy: potential of vasorelaxant agents.- Intracavernosal therapy: confirmation of response.- Yohimbine: modest effects as an oral monotherapy.- Intracavernosal alprostadil: rationale for use.- Intracavernosal alprostadil: long-term efficacy & safety.- Intracavernosal therapy: combination of vasoactive agents.- Intraurethral alprostadil.- Alprostadil: intracavernosal versus intraurethral.- Sildenafil: pilot study of first effective oral agent.- Sildenafil: utility confirmed.- Apomorphine SL: pilot study of an alternative oral agent.- Apomorphine SL: a viable alternative oral agent.- Phentolamine: a potential oral agent.- Testosterone therapy in androgen defficient men.- Psychotherapy.- Vacuum device.- Penile prostheses.